Neurology·Kissimmee, FL

University of Central Florida/HCA Florida Healthcare (Greater Orlando/Osceola)

Signal lift33%76%+43 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
229–260
p10 – p90
Sample N
607
applicants this cycle
This cycle
no tracked aways yet
Match rate
0.7%
4 of 47 applicants
01Cohort funnelthis cycle
N = 607
Applied
607
100.0%
Invited
47
7.7%
Class size
4
0.7%
J-1 visaCategorical
Your fitUniversity of Central Florida/HCA Florida Healthcare (Greater Orlando/Osceola) Program

Create a free profile to see your personalized fit

Get started
Contact
MZ
Program Director
Muhammad-Atif Zubairi, MD
Email director
KR
Program Coordinator
Kelly Roman, MD
Email coordinator
Training sites4 hospitals · Orlando
  • 1
    HCA Florida Osceola Hospital
    Kissimmee, FL
    Primary
  • 2
    University of Central Florida/HCA Florida Healthcare
    Orlando, FL
    Sponsor
  • 3
    Orlando VA Medical Center
    Orlando, FL
    Participant
  • 4
    Nemours Children's Hospital
    Orlando, FL
    Participant
Score rangesinvited cohort
USMLE Step 2 CK229260
180205230255280

Level 2 CE data not available

Interview rates
US MD
27%
US DO
11%
US IMG
8%
Non-US IMG
1%
Applicant origin
In-state
57%
Out-of-state
6%
Interview prepNeurology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesNeurology · 25-26
Save this program

Add University of Central Florida/HCA Florida Healthcare (Greater Orlando/Osceola) to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Neurology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.